No fee unless we recover compensation for your family Text size 833-4-ASBESTOS (833-427-2378) Free Case Review

Inactivation by Polymers of Hemolytic Microparticles in Vitro

You don't need the product names or old records. No fee unless we recover compensation for your family.

Call 833-4-ASBESTOS Request a review

In this test-tube study, the authors examined whether polymers (large chain-like chemicals) bound to mineral dusts would stop the dusts from breaking open red blood cells, an effect called hemolysis. They used standard reference samples of four asbestos types (chrysotile B, amosite, crocidolite and anthophyllite) and several silica dusts. Usually 100 mg of mineral was mixed with a polymer, washed three times to remove unbound polymer, and then added to sheep red blood cells. Chrysotile B lost about 80 to 90 percent of its hemolytic activity, especially after treatment with the polymers SA, CMC, NSC 46015 and CS. Crocidolite was inactivated somewhat less. Anthophyllite responded markedly to the uncharged polymer PVP, an exception to the usual pattern. With silica, PVP reduced hemolytic activity by 80 to 90 percent. The amount of fiber also mattered: 1.0 mg of SA gave 40 percent inactivation with 100 mg of chrysotile B, but more with smaller amounts of fiber. The authors concluded that asbestos and silica can be deprived of hemolytic action by comparatively small amounts of polymers. They said the mechanisms cannot yet be definitively interpreted.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

Author
R.J. Schnitzer, S. Senrui
Published by
Mt. Sinai School of Medicine, Environmental Sciences Laboratory
Library no.
ACL Doc 25462 · asbestosclaims.law/library/25462
Rights
J-M medical library, owner decided "Publish with commentary" in the J-M Rights Check table

Read or download

Read online Download the PDF PDF · 25 pages · 2.1 MB

From J-M's medical library

This copy comes from the Johns-Manville medical library. It was among the papers J-M kept in its medical library without an index entry.

We publish this piece for research and commentary: it shows what the medical literature in a leading asbestos company's own library said on the subject, and when. Our summary above is our own reading of it. The copyright stays with the publisher.

Cite this document

R.J. Schnitzer, S. Senrui. “Inactivation by Polymers of Hemolytic Microparticles in Vitro.” Mt. Sinai School of Medicine, Environmental Sciences Laboratory. AsbestosClaims.Law Library, ACL Doc 25462. https://asbestosclaims.law/library/25462.

ACL Doc numbers and their short links never change. See how to cite the Library.

Talk with an asbestos lawyer

Start with what you remember, and we'll take it from there.

This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.